Filing Details

Accession Number:
0000014272-16-000257
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-06 16:40:39
Reporting Period:
2016-01-04
Filing Date:
2016-01-06
Accepted Time:
2016-01-06 16:40:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208099 Lamberto Andreotti Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2016-01-04 11,500 $66.92 322,124 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2016-01-04 100 $67.52 322,024 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2016-01-05 11,000 $68.16 311,024 No 4 S Direct
Common Stock, $0.10 Par Value Disposition 2016-01-05 600 $68.78 310,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.10 Par Value 100,000 Indirect 2015 Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2015.
  2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $66.40 to $67.35, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.66 to $68.57, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  4. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $68.73 to $68.85, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.